4//SEC Filing
Gallen Christopher C. 4
Accession 0001181431-10-001234
CIK 0001135906other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:08 PM ET
Size
6.1 KB
Accession
0001181431-10-001234
Insider Transaction Report
Form 4
COMBINATORX, INCCRXX
Gallen Christopher C.
DirectorPresident &CEO
Transactions
- Other
Common Stock
2010-01-01−978,291→ 1,239,733 total
Footnotes (2)
- [F1]Because FDA approval of the product candidate Exalgo was not obtained on or prior to December 31, 2009, these shares were forfeited pursuant to the terms of the Escrow Agreement, dated as of June 30, 2009, by and among CombinatoRx, Incorporated ("CombinatoRx"), Neuromed Pharmaceuticals Inc., the Stockholder Representative named therein and Computershare Trust Company N.A., as Escrow Agent (the "Escrow Agreement"), and as described in the Joint Proxy Statement/Prospectus dated October 22, 2009 and the Joint Proxy Statement/Prospectus Supplement thereto, dated December 2, 2009, both filed by CombinatoRx with the Securities and Exchange Commission.
- [F2]Includes an aggregate of 650,703 shares (the "Holdback Shares") and an aggregate of 586,974 shares (the "Milestone Shares") (together, the "Escrow Shares"). The Escrow Shares are subject to forfeiture at various dates ranging from September 30, 2010 to December 31, 2010 pursuant to the terms and conditions of the Escrow Agreement.
Documents
Issuer
COMBINATORX, INC
CIK 0001135906
Entity typeother
Related Parties
1- filerCIK 0001476446
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:08 PM ET
- Size
- 6.1 KB